EUVIMEDEUVIMED entdecken
Scoping Review

Efficacy of Lavandula angustifolia Mill. on DSM-5–Defined Depressive Symptoms, Sleep Quality, and Fatigue: A Scoping Review of Randomized Controlled Trials

Sutude Fazilat, Mohammad Reza Mirzaei, Sarvin Sanaie, Ahad Banagozar Mohammadi, Mostafa Araj-Khodaei

International Journal of Drug Research in Clinics · 01.01.2026 · 4 · e9119

DOI: 10.34172/ijdrc.9119 ↗

Kurz gefasst

Scoping Review in der Zeitschrift International Journal of Drug Research in Clinics, online erschienen am 19.06.2026. Verfasst von Sutude Fazilat und 4 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Depression and its associated symptoms, including sleep disturbances and fatigue, are highly prevalent and substantially impair the quality of life. Lavandula angustifolia Mill. has emerged as a promising complementary therapy. However, a comprehensive synthesis of its efficacy on specific DSM-5–defined depressive symptoms remains unavailable. Accordingly, this scoping review was performed to chart randomized, placebo-controlled trial evidence on L. angustifolia interventions for DSM-5 depressive symptoms and to guide future research priorities and clinical practices.

Methods

To this end, PubMed was searched from inception to May 28, 2025, for randomized, placebo-controlled clinical trials evaluating any L. angustifolia Mill. formulation for DSM-5–defined depressive symptoms. Data were synthesized narratively.

Results

Thirteen randomized controlled trials met the inclusion criteria. Trials consistently reported that L. angustifolia Mill. improved sleep quality across diverse populations, including postmenopausal women and older adults, and significantly reduced fatigue in patients with high disease burden. Similarly, several studies demonstrated sharp reductions in overall depressive symptom scores, particularly in cases of mild depression and when used adjunctively. Finally, adverse events were infrequent and mild, indicating favorable tolerability.

Conclusion

It was revealed that L. angustifolia Mill. demonstrates potential as a complementary intervention for selected depressive symptoms, sleep quality, and fatigue. Nonetheless, heterogeneity in study designs, outcome measures, and product formulations underscores the need for further high-quality, standardized trials to inform evidence-based clinical guidelines.

Zitieren

APA

Fazilat, S., Mirzaei, M. R., Sanaie, S., Mohammadi, A. B., & Araj-Khodaei, M. (2026). Efficacy of Lavandula angustifolia Mill. on DSM-5–Defined Depressive Symptoms, Sleep Quality, and Fatigue: A Scoping Review of Randomized Controlled Trials. International Journal of Drug Research in Clinics, 4, e9119. https://doi.org/10.34172/ijdrc.9119

Vancouver

Fazilat S, Mirzaei MR, Sanaie S, Mohammadi AB, Araj-Khodaei M. Efficacy of Lavandula angustifolia Mill. on DSM-5–Defined Depressive Symptoms, Sleep Quality, and Fatigue: A Scoping Review of Randomized Controlled Trials. International Journal of Drug Research in Clinics. 2026;4:e9119. doi:10.34172/ijdrc.9119

BibTeX
@article{Fazilat2026,
  author = {Fazilat, Sutude and Mirzaei, Mohammad Reza and Sanaie, Sarvin and Mohammadi, Ahad Banagozar and Araj-Khodaei, Mostafa},
  title = {Efficacy of Lavandula angustifolia Mill. on DSM-5–Defined Depressive Symptoms, Sleep Quality, and Fatigue: A Scoping Review of Randomized Controlled Trials},
  journal = {International Journal of Drug Research in Clinics},
  year = {2026},
  volume = {4},
  pages = {e9119},
  doi = {10.34172/ijdrc.9119}
}
Kostenlos starten →